PBM Formulary Exclusions In Oncology Are On The Rise
Physician-Administered Drugs Make Up Nearly Half Of Oncology Exclusions
Oncology drugs are no longer immune to pharmacy benefit management formulary exclusions in the commercial market and even drugs administered in a physician’s office are increasingly being subjected to rebate-driven coverage decisions.
